-+ 0.00%
-+ 0.00%
-+ 0.00%

Klaria Pharma Plans TO1 Warrant Listing on Nasdaq First North Around Nov. 30, 2026

PUBT·11/13/2026 17:47:02
Klaria Pharma Plans TO1 Warrant Listing on Nasdaq First North Around Nov. 30, 2026
  • Klaria Pharma plans to use rights issue proceeds to strengthen its finances, settle short-term liabilities and execute its commercial strategy.
  • Cash proceeds will total approximately SEK 73.8 million before issue costs and loan repayments; approximately SEK 37.3 million will offset claims.
  • Full exercise of series TO1 warrants could provide approximately SEK 27.8 million before issue costs.
  • Plans include listing the series TO1 warrants on Nasdaq First North Growth Market, with trading expected around November 30, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 20261113:BIT:9099:0) on November 13, 2026, and is solely responsible for the information contained therein.